findmyKOL
Clinical trialNCT02737046CompletedPhase 2Interventional

Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

SponsorUniversity of MiamiEnrollment15ATLLAdult T-cell Leukemia-Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The investigators propose to use Belinostat in combination with AZT as consolidation therapy for the treatment of ATLL.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Miami

    Miami, Florida, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Belinostat →Interferon alfa-2bLymphodepleting TherapyPegylated Interferon-Alfa-2bZidovudine →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Dec 2016
Primary completion
31 Dec 2024
Completion
31 Dec 2025
Last update posted
10 Mar 2026
Registered enrollment
15
Registry id
NCT02737046
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.